Evidence map›Paper›PMID 33427970›Full record

ArticleWorld journal of microbiology & biotechnology2021

Bacteriocin isolated from the natural inhabitant of Allium cepa against Staphylococcus aureus.

Ramita Taggar, Manoj Jangra, Akanksha Dwivedi, Kanika Bansal, Prabhu B Patil, Mani Shankar Bhattacharyya, Hemraj Nandanwar, Debendra K Sahoo

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Antibacterial Activity and Mechanism ofPlants (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. The Bro-Xre toxin-antitoxin modules inFrontiers in microbiology · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ramita TaggarBiochemical Engineering Research and Process Development Centre, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, 160036, India.
Manoj JangraClinical Microbiology & Bioactive Screening Laboratory, CSIR-Institute of Microbial Technology, 160036, Chandigarh, India.
Akanksha DwivediBiochemical Engineering Research and Process Development Centre, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, 160036, India.
Kanika BansalBacterial Genomics and Evolution Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
Prabhu B PatilBacterial Genomics and Evolution Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
Mani Shankar BhattacharyyaBiochemical Engineering Research and Process Development Centre, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, 160036, India.
Hemraj NandanwarClinical Microbiology & Bioactive Screening Laboratory, CSIR-Institute of Microbial Technology, 160036, Chandigarh, India.
Debendra K SahooBiochemical Engineering Research and Process Development Centre, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, 160036, India. debsahoo@imtech.res.in.ORCID http://orcid.org/0000-0001-7460-3638
Institute of Microbial Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extensive usage of antibiotics has led to the emergence of drug-resistant strains of pathogens and hence, there is an urgent need for alternative antimicrobial agents. Antimicrobial Peptides (AMPs) of bacterial origin have shown the potential to replace some conventional antibiotics. In the present study, an AMP was isolated from Bacillus subtilis subsp. spizizenii strain Ba49 present on the Allium cepa, the common onion and named as peptide-Ba49. The isolated AMP was purified and characterized. The purified peptide-Ba49, having a molecular weight of ~ 3.3 kDa as determined using mass spectroscopy, was stable up to 121 °C and in the pH range of 5-10. Its interaction with protein degrading enzymes confirmed the peptide nature of the molecule. The peptide exhibited low minimum inhibitory concentration (MIC) against Staphylococcus aureus and its (Methicillin-resistant Staphylococcus aureus) MRSA strains (MIC, 2-16 µM/mL). Further, time kill kinetic assay was performed and analysis of the results of membrane depolarization and permeabilization assays (TEM, DiBAC

Indexed as

AnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacillusBacteriocinsHEK293 CellsHumansHydrogen-Ion ConcentrationKineticsMethicillin-Resistant Staphylococcus aureusMiceMicrobial Sensitivity TestsMultigene FamilyOnionsPlant ExtractsRAW 264.7 CellsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacteriocinsPlant ExtractsAntimicrobial peptides (AMPs)DiBAC4 (3)MRSAPropidium iodideStaphylococcus aureus

Identifiers

PMID33427970
OpenAlexW3119286964

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.